Otake Corporation
Notice Regarding Formulation of Recurrence Prevention Measures
Following receipt of the Special Investigation Committee's report, the company has decided on recurrence prevention measures. Certain business practices were identified as potentially violating the Antimonopoly Act, attributed to excessive competition and corporate culture issues. The company will fundamentally strengthen its compliance framework and enhance internal controls, education, and whistleblower systems. Senior management will issue messages quarterly, and the company will revise internal rules and strengthen the board of directors' functions.
Key Figures
- Key Figure 1: Unknown (no specific numeric values are provided in the report text)
- Key Figure 2: Unknown
- Key Figure 3: Unknown
AI要約
Overview of Recurrence Prevention Measures
After receiving the Special Investigation Committee's report, the company will pursue a fundamental strengthening of its compliance framework. Senior management will deliver clear messages quarterly, and the company will establish and enforce internal rules that, in principle, prohibit contact with competitors. In addition, the company plans to enhance the board of directors' supervisory function, review internal controls, strengthen compliance training, and improve the effectiveness of the whistleblower system, with the aim of improving organizational culture and the quality of internal audits.
Impact and Future Initiatives
The recurrence prevention measures aim to enforce company-wide codes of conduct and strengthen compliance systems to restore trust with shareholders and investors. Specific initiatives include operating transaction rules that do not presume contact with competitors, considering job rotation, ensuring the effectiveness of supervisory functions, conducting ongoing training, and expanding the internal reporting system.
Otake Corporation
Company overview · Stock price · Financial data · All IR
